Assessment of the underreporting of rhinitis in patients with asthma: A MASK-air® real-world study DOI Creative Commons
Bernardo Sousa‐Pinto, Gilles Louis, Rafael José Vieira

et al.

Pulmonology, Journal Year: 2024, Volume and Issue: 31(1)

Published: Nov. 4, 2024

Rhinitis is a common comorbidity in patients with asthma. However, the frequency of underreported rhinitis asthma not known. In this study, we aimed to assess characteristics self-reported and no rhinitis, as well extent underreporting rhinitis. We performed cross-sectional study all MASK-airⓇ users (2015-2022, 27 countries), comparing reported symptoms medication use (i) without ("asthma alone"), (ii) rhinitis+asthma (iii) ("rhinitis alone"). reporting alone providing data at least three different months, cluster analysis was potentially identify groups and/or undertreated for assessed 35,251 (529,751 days): 671 (1.9%) 25,882 (73.4%) 8698 (24.7%) rhinitis+asthma. Overall, 27% were treated medications. Patients displayed lower days under less severe nasal than those Among alone, clusters identified: (A; 22.2%) low use, (B, 41.0%) moderate high (41.0%), (C, 36.8%) mild or almost use. This suggests that, among asthma, undertreatment may be common.

Language: Английский

Digitally‐enabled, person‐centred care (PCC) in allergen immunotherapy: An ARIA‐EAACI Position Paper DOI Creative Commons
Oliver Pfaar, Bernardo Sousa‐Pinto, Nikolaos G. Papadopoulos

et al.

Allergy, Journal Year: 2024, Volume and Issue: 79(8), P. 2037 - 2050

Published: May 3, 2024

Abstract In rhinitis and asthma, several mHealth apps have been developed but only a few validated. However, these high potential for improving person‐centred care (PCC), especially in allergen immunotherapy (AIT). They can provide support AIT initiation by selecting the appropriate patient shared decision‐making. also help (i) evaluation of (early) efficacy, (ii) early late stopping rules (iii) (carried‐over) efficacy after cessation treatment course. Future perspectives formulated first report joint task force (TF)—Allergic Rhinitis Its Impact on Asthma (ARIA) European Academy Allergy Clinical Immunology (EAACI)—on digital biomarkers. The TF now aims to outline clinical applications solutions, express their current limitations, make proposals regarding further developments both practice scientific purpose (iv) suggest which tools might best comply with digitally‐enabled PCC AIT.

Language: Английский

Citations

4
Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024) DOI Creative Commons
Jean Bousquet, Holger J. Schünemann,

Bernardo Sousa-Pinto

et al.

The Journal of Allergy and Clinical Immunology In Practice, Journal Year: 2024, Volume and Issue: 12(10), P. 2648 - 2668.e2

Published: July 4, 2024

The traditional healthcare model is focused on diseases (medicine and natural science) does not acknowledge patients' resources abilities to be experts in their own lives based lived experiences. Improving safety, quality, coordination, as well quality of life, an important aim the care patients with chronic conditions. Person-centered needs ensure that people's values preferences guide clinical decisions. This paper reviews current knowledge develop (1) digital pathways for rhinitis asthma multimorbidity (2) digitally enabled, person-centered care.

Language: Английский

Citations

4
Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024 DOI Creative Commons
Peter W. Hellings, Diego M. Conti, Xander Bertels

et al.

Frontiers in Allergy, Journal Year: 2025, Volume and Issue: 6

Published: Feb. 24, 2025

In April 2024, the European Summit "Raising bar in respiratory care" was organized by Forum for Research and Education Allergy Airway Diseases (EUFOREA) Parliament hosted Members of Dorien Rookmaker Mislav Kolakušić. The aim to respond need patients suffering from chronic diseases (CRDs) joining forces with global organisations management epidemics CRD, recognising weaknesses current care models focussing on collaboration improve prevention. Participants belonging International National Societies Committees Rhinologic Society (ERS), (IRS), Belgian Respiratory (BeRS), Global Initiative Asthma (GINA), Chronic Obstructive Lung Disease (GOLD), Alliance against (GARD), Federation Airways Patients Associations (EFA) EUFOREA's Patient Advisory Board (PAB) described their vision action plan work partnership raise care. This report summarizes contributions representatives different stakeholders field CRDs.

Language: Английский

Citations

0
A capsule network-based public health prediction system for chronic diseases: clinical and community implications DOI Creative Commons
Haiyan Xie

Frontiers in Public Health, Journal Year: 2025, Volume and Issue: 13

Published: March 14, 2025

To observe the role of a public health chronic disease prediction method based on capsule network and information system in clinical treatment management. Patients with hypertension, diabetes, asthma admitted from May 2022 to October 2023 were incorporated into research. They grouped hypertension group (n = 341), diabetes 341). The established was used diagnose these types diseases. key influencing factors obtained by compared regression analysis results. In addition, its diagnostic accuracy specificity analyzed, value this explored. This applied management approach improved distribution prevalence effectiveness residents' acceptance before after improvement compared, application affecting three diseases methods found be significantly correlated occurrence (p < 0.05). Compared application, accuracy, sensitivity values 88.6, 89 92%, respectively, which higher than empirical doctors other existing AI-based methods, AUC proposed theirs indicates that study has accuracy. After applying management, wellbeing individuals conditions community notably improved, incidence rate reduced level residents toward work departments also raised systems high diagnosis can help physicians accurately patients' conditions. Management adjust strategies timely manner through predictive results propose targeted measures characteristics community.

Language: Английский

Citations

0
Use of Technology to Improve Adherence in Allergy/Immunology DOI

John Oppenheimer,

Bruce G. Bender,

Bernardo Sousa‐Pinto

et al.

The Journal of Allergy and Clinical Immunology In Practice, Journal Year: 2024, Volume and Issue: unknown

Published: July 1, 2024

Language: Английский

Citations

2
Impact of allergic rhinitis control on work productivity and costs: a real-world data MASK-air study DOI
Rafael José Vieira, Luís Filipe Azevedo, Ana Margarida Pereira

et al.

The Journal of Allergy and Clinical Immunology In Practice, Journal Year: 2024, Volume and Issue: 12(11), P. 3107 - 3115.e13

Published: Aug. 5, 2024

Language: Английский

Citations

2
Managing Asthma and Allergies during the Russo-Ukrainian War DOI Creative Commons
Ігор Петрович Кайдашев,

Eugenia Ditiatkovskaya

Annals of Allergy Asthma & Immunology, Journal Year: 2024, Volume and Issue: 133(6), P. 720 - 721

Published: Sept. 3, 2024

Language: Английский

Citations

2
Assessment of the underreporting of rhinitis in patients with asthma: A MASK-air® real-world study DOI Creative Commons
Bernardo Sousa‐Pinto, Gilles Louis, Rafael José Vieira

et al.

Pulmonology, Journal Year: 2024, Volume and Issue: 31(1)

Published: Nov. 4, 2024

Rhinitis is a common comorbidity in patients with asthma. However, the frequency of underreported rhinitis asthma not known. In this study, we aimed to assess characteristics self-reported and no rhinitis, as well extent underreporting rhinitis. We performed cross-sectional study all MASK-airⓇ users (2015-2022, 27 countries), comparing reported symptoms medication use (i) without ("asthma alone"), (ii) rhinitis+asthma (iii) ("rhinitis alone"). reporting alone providing data at least three different months, cluster analysis was potentially identify groups and/or undertreated for assessed 35,251 (529,751 days): 671 (1.9%) 25,882 (73.4%) 8698 (24.7%) rhinitis+asthma. Overall, 27% were treated medications. Patients displayed lower days under less severe nasal than those Among alone, clusters identified: (A; 22.2%) low use, (B, 41.0%) moderate high (41.0%), (C, 36.8%) mild or almost use. This suggests that, among asthma, undertreatment may be common.

Language: Английский

Citations

0